HYVISC is available only in the United States and is distributed by Boehringer Ingelheim Vetmedica, Inc. Part of the Boehringer Ingelheim group of companies based in Germany, Boehringer Ingelheim Vetmedica manufactures and markets an extensive line of high quality biological and pharmaceutical products for cattle, swine, horses and pets.
Products of other enterprises
HYVISC® is a highly viscous, high molecular weight, extremely pure injectable formulation of hyaluronic acid (HA) for the treatment of joint dysfunction in horses associated with equine osteoarthritis. Equine practitioners choose HYVISC because of its ease of use, efficacy, purity and economy.
Contact the seller
HYVISC® Injections for the Treatment of Equine' Osteoarthritis
We recommend to see